Qualium, a private equity firm, led a €90m investment in  ChapsVision, a data valorization specialist, with participation from Geneo, Tikehau Capital and Bpifrance. “I am delighted to be able to welcome such high-profile investors such as Qualium Investissement and GENEO to join us as partners in our development. We would also like to thank Tikehau Capital and Bpifrance for renewing their faith in us. We have completed a significant step in the growth of the ChapsVision group, which will give us the resources to intensify our dynamic growth strategy. This major financing will enable the Group to meet our targets of €180 M in revenues by the end of 2023, and €250 M of revenues by the end of 2024, and therefore position ChapsVision as a leading European and sovereign provider of mass data processing solutions,” Olivier Dellenbach, ChapsVision CEO and Founder.